Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Guangji Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical enterprise specializing in the production of vitamins and pharmaceutical intermediates. The company is a global leader in the production of Riboflavin (Vitamin B2), leveraging large-scale fermentation technology to supply both domestic and international markets. In addition to its core vitamin business, it manufactures Vitamin B6 and a range of finished dosage forms including tablets, capsules, and infusions. Founded in 1969 and headquartered in Wuxue, Hubei, the company is listed on the Shenzhen Stock Exchange. Its operations integrate research, development, and high-capacity manufacturing to support the global nutritional and healthcare industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 湖北广济.